Physician profile
David E Sahar
NPI 1235314121
$3,475.93
in general payments reported to CMS, 2019-2025
14 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $20.43 · 2021: $466 · 2022: $520 · 2023: $309 · 2024: $1,543 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,029 · Travel and Lodging: $972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.33 |
| Travel and Lodging | $971.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,654.83 | 2024-2025 | |
| Sientra, INC. | $606.36 | 2019-2022 | |
| Integra Lifesciences Corporation | $346.51 | 2019-2022 | |
| Tei Biosciences INC | $129.51 | 2019 | |
| Smith+Nephew, INC. | $122.56 | 2023-2024 | Grafix Pl, Stravix Pl |
| Mentor Worldwide LLC | $112.97 | 2022-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $111.10 | 2021 | |
| Organogenesis INC. | $107.74 | 2023 | Puraply |
| Allergan, INC. | $105.53 | 2021 | |
| Mallinckrodt Enterprises LLC | $58.67 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $48.51 | 2021 | |
| Axogen | $35.65 | 2021 | |
| Boston Scientific Corporation | $19.37 | 2023 | |
| Caris Mpi, INC. | $16.62 | 2025 | Mi Cancer Seek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sahar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.